Vivesto AB (FRA:OMA) Total Liabilities: €1.05 Mil (As of Mar. 2026)


FRA:OMA Vivesto AB FRA:OMA
33 GF Score
Price €0.70
! 1 Warning Sign
View Full Analysis

What is Vivesto AB Total Liabilities?

Vivesto AB FRA:OMA -1.68% 33 Total Liabilities is €1.05 Mil as of Mar. 2026. GuruFocus rates FRA:OMA with a GF Score™ of 33/100. The stock has 1 warning sign investors should review.

Vivesto AB's Total Liabilities for the quarter that ended in Mar. 2026 was €1.05 Mil.

Vivesto AB's quarterly Total Liabilities increased from Sep. 2025 (€1.49 Mil) to Dec. 2025 (€2.25 Mil) but then declined from Dec. 2025 (€2.25 Mil) to Mar. 2026 (€1.05 Mil).

Vivesto AB's annual Total Liabilities declined from Dec. 2023 (€2.05 Mil) to Dec. 2024 (€1.27 Mil) but then increased from Dec. 2024 (€1.27 Mil) to Dec. 2025 (€2.25 Mil).

Vivesto AB Total Liabilities Historical Data

* Premium members only.

The historical data trend for Vivesto AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vivesto AB Total Liabilities Chart

Vivesto AB Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.34 2.03 2.05 1.27 2.25

Vivesto AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.90 1.10 1.49 2.25 1.05
FRA:OMA
33GF Score
Vivesto AB FRA:OMA
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vivesto AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Vivesto AB's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.248+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=2.25

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=13.696-11.448
=2.25

Vivesto AB's Total Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.049+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.05

Total Liabilities=Total Assets (Q: Mar. 2026 )-Total Equity (Q: Mar. 2026 )
=16.512-15.463
=1.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €1.05 Mil mean?
Vivesto AB (FRA:OMA) has a Total Liabilities of €1.05 Mil as of Mar. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Vivesto AB and its competitors.
Is Vivesto AB's Total Liabilities too high?
Vivesto AB's current Total Liabilities is €1.05 Mil. Overall, Vivesto AB has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Vivesto AB's Total Liabilities compare to ZTS and UTHR?
Vivesto AB's Total Liabilities of €1.05 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Vivesto AB and its competitors. Vivesto AB's current Total Liabilities is €1.05 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivesto AB stock overvalued right now?
Vivesto AB (FRA:OMA) has a current Total Liabilities of €1.05 Mil. The current Total Liabilities is €1.05 Mil. Vivesto AB's overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Vivesto AB (FRA:OMA), the current Total Liabilities is €1.05 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vivesto AB Business Description

Other Exchanges VIVE:Sweden
Address Gustav III:s Boulevard 46, 5th Floor, Solna, SWE, SE-169 73
Vivesto AB is a research and development company that develops new treatment options for patients suffering from difficult-to-treat cancer. The company's product development leverages its proprietary technology platforms to manufacture novel drug formulations that are intended to demonstrate improved properties in comparison with current alternatives, which can lead to a reduced side-effect profile and an expanded therapeutic area. The company has a portfolio of projects targeting cancer treatments.
33GF Score

Get the complete analysis for FRA:OMA

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.70
Price